85 related articles for article (PubMed ID: 2180981)
1. Effects of growth hormone (GH) on plasma bone Gla protein in GH-deficient adults.
Johansen JS; Pedersen SA; Jørgensen JO; Riis BJ; Christiansen C; Christiansen JS; Skakkebaek NE
J Clin Endocrinol Metab; 1990 Apr; 70(4):916-9. PubMed ID: 2180981
[TBL] [Abstract][Full Text] [Related]
2. Serum bone Gla protein: a potential marker of growth hormone (GH) deficiency and the response to GH therapy.
Johansen JS; Jensen SB; Riis BJ; Rasmussen L; Zachmann M; Christiansen C
J Clin Endocrinol Metab; 1990 Jul; 71(1):122-6. PubMed ID: 2370291
[TBL] [Abstract][Full Text] [Related]
3. Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects.
Amato G; Izzo G; La Montagna G; Bellastella A
Clin Endocrinol (Oxf); 1996 Jul; 45(1):27-32. PubMed ID: 8796135
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of bone Gla protein (osteocalcin, BGP) and carboxyterminal propeptide of type I procollagen (PICP) in acromegaly: effects of long-term octreotide treatment.
Terzolo M; Piovesan A; Osella G; Pia A; Reimondo G; Pozzi C; Raucci C; Torta M; Paccotti P; Angeli A
Calcif Tissue Int; 1993 Mar; 52(3):188-91. PubMed ID: 8481830
[TBL] [Abstract][Full Text] [Related]
5. [Effect of GH/IGF-I deficiency on bone and collagen turnover in children and adults with GH deficiency].
Sartorio A; Conti A; Monzani M; Ferrero S; Biella O; Casati G; Faglia G
Minerva Endocrinol; 1995 Jun; 20(2):135-40. PubMed ID: 8531895
[TBL] [Abstract][Full Text] [Related]
6. Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome.
Piovesan A; Terzolo M; Reimondo G; Pia A; Codegone A; Osella G; Boccuzzi A; Paccotti P; Angeli A
Horm Metab Res; 1994 May; 26(5):234-7. PubMed ID: 8076906
[TBL] [Abstract][Full Text] [Related]
7. Serum bone GLA-protein in growth hormone deficient children.
Delmas PD; Chatelain P; Malaval L; Bonne G
J Bone Miner Res; 1986 Aug; 1(4):333-8. PubMed ID: 3509741
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group.
Longobardi S; Keay N; Ehrnborg C; Cittadini A; Rosén T; Dall R; Boroujerdi MA; Bassett EE; Healy ML; Pentecost C; Wallace JD; Powrie J; Jørgensen JO; Saccà L
J Clin Endocrinol Metab; 2000 Apr; 85(4):1505-12. PubMed ID: 10770189
[TBL] [Abstract][Full Text] [Related]
9. Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients.
Scillitani A; Chiodini I; Carnevale V; Giannatempo GM; Frusciante V; Villella M; Pileri M; Guglielmi G; Di Giorgio A; Modoni S; Fusilli S; Di Cerbo A; Liuzzi A
J Bone Miner Res; 1997 Oct; 12(10):1729-36. PubMed ID: 9333135
[TBL] [Abstract][Full Text] [Related]
10. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH.
Bengtsson BA; Edén S; Lönn L; Kvist H; Stokland A; Lindstedt G; Bosaeus I; Tölli J; Sjöström L; Isaksson OG
J Clin Endocrinol Metab; 1993 Feb; 76(2):309-17. PubMed ID: 8432773
[TBL] [Abstract][Full Text] [Related]
11. Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study.
Hansen TB; Brixen K; Vahl N; Jørgensen JO; Christiansen JS; Mosekilde L; Hagen C
J Clin Endocrinol Metab; 1996 Sep; 81(9):3352-9. PubMed ID: 8784096
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
[TBL] [Abstract][Full Text] [Related]
13. Effects of short-term insulin-like growth factor-I (IGF-I) or growth hormone (GH) treatment on bone metabolism and on production of 1,25-dihydroxycholecalciferol in GH-deficient adults.
Bianda T; Glatz Y; Bouillon R; Froesch ER; Schmid C
J Clin Endocrinol Metab; 1998 Jan; 83(1):81-7. PubMed ID: 9435420
[TBL] [Abstract][Full Text] [Related]
14. The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults.
Schlemmer A; Johansen JS; Pedersen SA; Jørgensen JO; Hassager C; Christiansen C
Clin Endocrinol (Oxf); 1991 Dec; 35(6):471-6. PubMed ID: 1769127
[TBL] [Abstract][Full Text] [Related]
15. Effect of active acromegaly and its treatment on parathyroid circadian rhythmicity and parathyroid target-organ sensitivity.
White HD; Ahmad AM; Durham BH; Chandran S; Patwala A; Fraser WD; Vora JP
J Clin Endocrinol Metab; 2006 Mar; 91(3):913-9. PubMed ID: 16352693
[TBL] [Abstract][Full Text] [Related]
16. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency.
Magnusson P; Degerblad M; Sääf M; Larsson L; Thorén M
J Bone Miner Res; 1997 Feb; 12(2):210-20. PubMed ID: 9041052
[TBL] [Abstract][Full Text] [Related]
17. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
[TBL] [Abstract][Full Text] [Related]
18. Correlation among plasma osteocalcin, growth hormone, and somatomedin C in acromegaly.
de la Piedra C; Larrañaga J; Castro N; Horcajada C; Rapado A; Herrera Pombo JL; Carbó E
Calcif Tissue Int; 1988 Jul; 43(1):44-5. PubMed ID: 3145120
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study Group.
Murphy MG; Bach MA; Plotkin D; Bolognese J; Ng J; Krupa D; Cerchio K; Gertz BJ
J Bone Miner Res; 1999 Jul; 14(7):1182-8. PubMed ID: 10404019
[TBL] [Abstract][Full Text] [Related]
20. 24-h profile of serum osteocalcin in growth hormone (GH) deficient patients with and without GH treatment.
Nielsen HK; Jørgensen JO; Brixen K; Møller N; Charles P; Christensen JS
Growth Regul; 1991 Dec; 1(4):153-9. PubMed ID: 1842347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
